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DICULORMAPTIARSEN IN THE TREATMENT OF SYPHILIS 1,2,3
GIRSCH D. ASTRACHAN, M.D.
Dichiormapharsen (3 amino-4 hydroxyphenyl-dichiorarsine-hydrochioride)
is a white crystalline powder, containing 25.8 per cent of arsenic in trivalent form.
It is supplied as a mixture with sodium carbonate (anhydrous), sodium chloride,
sucrose and ascorbic acid (1).
Dichlorarsine hydrochloride was studied by several authors (2, 3, 4, 5, 6) who
found it to be an efficacious antisyphilitic drug of low toxicity. The present
work with dichiormapharsen was begun in December 1941 and to date 253 pa-
tients have been treated; 79 from the Skin and Cancer Unit of the New York
Post-Graduate Medical School and Hospital, (service of Dr. Fred Wise); 159
from the Metropolitan Hospital and Dispensary (service of Dr. Van Aistyne
Cornell); and 15 from my private practice. There were 85 women and 168 men.
The maximum age was 60, the minimum was 14.
There were 9 cases of seronegative primary, 52 of seropositive primary, 43
of early secondary syphilis, 16 late secondary syphilis, 11 with tertiary skin
manifestations, 101 with late latent syphilis, 11 with early latent syphilis, 4 with
asymptomatic neurosyphilis and 6 with late congenital syphilis.
A total number of 4366 injections was given. In 194 cases the injections were
given once or twice a week. The maximum dosage was 75 mgm., the minimum
dosage was 5 mgm. Bismuth was given concurrently once a week in the early
cases. In the late cases bismuth was given either concurrently or in alternate
courses with the arsenicals. In 59 cases the Eagle-Hogan method (7) was used;
and dichiormapharsen was given (approximately 1 mgm. per kilo of weight)
3 times a week, during 6—12 weeks; the maximum dosage was 100 mgm., the
minimum dosage was 10 mgm. Bismuth was given concurrently once a week.
EFFECT ON VISIBLE LESIONS
The average time required for the disappearance of primary lesions was 10.1 days; second-
ary eruptions 11.4 days; tertiary skin manifestations 38 days. The average number of
injections given for healing of primary lesions was 3.3 of dichlormapharsen (average dosage
46 mgm.) and 2 of bismuth, for secondary eruption 4 of dichlormapharsen (average dosage
56 mgm.) and 2 of bismuth, for tertiary skin lesions 5.5 of dichlormapharsen and 1.5 of bis-
muth. One case of generalized, papulo-squamous (psoriasiforin) syphilis healed in 7 weeks,
following 7 injections of dichlormapharsen (average dosage 40 mgm.). One case of rupia
syphilitica did not show any change following 2 injections of dichlormapharsen (average
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dosage 35 mgm.). One case of acute interstitial keratitis improved markedly following 3
injections of dichlormapharsen (total dosage 110 rngm.) and 4 injections of bismuth. One
patient, L. H., with arseno-resistant syphilis (8.9) of the face (infiltration, ulceration, scar-
ring) was observed. The nose, septum, bridge of nose and upper lip were completely
destroyed. The destructive process began in 1935 and progressed in spite of antisyphilitic
therapy, fever treatment and other medications. The ulceration on the face cleared up
almost completely following 6 bismuth and 7 dichlormapharsen injections (total amount
250 mgm.). A few months later the ulceration reappeared and gradually became worse in
spite of injections of dichlormapharsen. (The case was presented at the New York Acad-
emy of Medicine on 2/2/43 (8) and 4/3/43) (9).
As for the cases treated by the Eagle-Hogan method (7), the average amount of dichlor-
mapharsen required for the disappearance of primary lesions was 328 mgm.; secondary
lesions 345 mgm. Average time required for primary lesions was 11.9 days, secondary
lesions 12.8 days. Number of injections required for the disappearance of primary lesions
was 5.2 of the arsenical, and 2.2 of bismuth, for secondary lesions 5.6 of the arsenical and 2.5
of bismuth.
THE EFFECT OF DICHLORMAPHARSEN ON THE SEROLOGIC REACTION OF EARLY
SYPHILIS
Among the 120 cases of early syphilis, 59 were treated by the Eagle-Hogan method and the
results will be cited below. The other patients were treated with bi-weekly injections of
mapharsen and the concurrent administration of bismuth salicylate given once a week. (In
very few cases the mapharsen injections were given once a week.)
Among the patients who did not complete their treatment, but who received 10 or more
injections of dichlormapharsen, 12 out of 20 or 75 per cent showed a partial reversal of one
or both serologic reactions following 11.7 injections of dichlormapharsen (average total
amount 575 mgm.) and 8 injections of bismuth. In the remaining 8 cases the serologic re-
action did not change following the average of 11.1 injections of dichlormapharsen (total
average dosage 604 mgm.) and 5 injections of bismuth.
In 12 cases both serologic reactions became completely negative following an average
of 20.6 injections of dichiormapharsen, (average dosage 53 mgm., average total amount
given 1092 mgm.), and 13.4 injections of bismuth. The average time required for the re-
versal of both serologic reactions in these cases was 114 days.
In one of the cases, W. R., the reversal of both reactions occurred after 42 injections of
dichlormapharsen (total amount given 2184 mgm.) and 35 injections of bismuth were given.
This patient was very delinquent in his attendance and the injections were given at various
irregular intervals. The treatment was not continuous at times. If we should exclude this
case from the number of those with a complete reversal of the serologic reactions, the aver-
age number of dichlormapharsen injections necessary to reverse both serologic reactions
will be decreased. It will be 18.7 (average total amount 971 mgm.).
Among the cases of seronegative primary syphilis, the serologic reaction became positive
during treatment and reversed to negative in 2 cases (J. L., S. G.). The number of in-
jections given was 12.12. The total amount of dichlormapharsen given was 870, 870 mgm.
The total amount of dichiormapharsen given per kilo of weight was 11.6 mgm., 11.0 mgm.
In 2 other cases (S. F., E. G.) the negative serologic reactions remained negative after 10
and 14 injections, respectively, of dichlormapharsen were given. The total amount of
dichlormapharsen given was 460 mgm. and 810 mgm., and the total amount of dichiorma-
pharsen given per kilo of weight was 7.5 mgm., and 13.5 mgm.
Among the 59 patients with early syphilis who were treated by the Eagle and Hogan
method, 34 completed the treatment and received on the average 26.2 injections of dichlor-
niapharsen and 9 injections of bismuth. In 19 out of 34 or in 55.8 per cent of the cases the
serologic reactions reversed to negative (in 4 seronegative cases the serologic reactions
remained negative). In one case, P. M., the serologic reaction changed from negative to
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doubtful 3 months after completion of therapy. No treatment was given after that. A
few months later the patient was inducted into the army. It may be assumed that his
serologic reaction became negative again. This case is not however, included in the group
with satisfactory results.
In another case, H. G., the serologic reaction became and stayed negative for more than
2 years following the administration of 25 mgm. of dichiormapharsen (total amount given
1785 mgm.). The patient appeared in the Metropolitan Hospital about 25 months after
completion of therapy presenting a lichenoid papular eruption on the penis. He also gave a
history of having had a penile sore about one month before that. The serologic reaction was
positive (3+). In view of the fact that in this case it was difficult to differentiate between a
recurrence and reinfection, it is not included among the cases with satisfactory results.
In 6 out of 34 or in 17.6 per cent of the cases the serologic reaction reversed partially on or
about the time when the treatment was completed. In 7 out of 34 cases or in 20.6 per cent
the serologic reaction remained unchanged on or about the time when the treatment was
completed. Taking into consideration the fact that in the cases in which the serologic
reactions reversed partially, the improvement was present immediately following the
completion of the therapy, one is justified in believing that these 6 patients will probably
show further improvement in the serologic reactions within the next few months. If these
6 cases are added to the 19 in which the serologic reactions reversed to negative it may be
said that in 25 out of 34 or 73.4 per cent of the cases the results of the intensive therapy were
good.
The average number of injections of dichlormapharsen given before the serologic reaction
reversed to negative was 24.6. The average total amount of dichlormapharsen given before
the serologic reaction reversed to negative was 1406 mgm. (21.7 mgm. per kilo of weight).
EFFECT OF DICHLORMAPHARSEN ON THE SEROLOGIC REACTION OF LATENT
SYPHILITIC PATIENTS
(See Tables 1 and 2)
This question was studied in 60 cases. Among these were 54 of late latent syphilis and
6 of early latent syphilis. Among the 54 cases there were 35 (64.8 per cent) in which the
Wassermann or Kahn reaction or both, reversed partially or completely under the influence
of dichlormapharsen therapy. The serologic reaction did not improve in 19 cases (35.2
per cent). Among these cases were 5 with irreducible serologic reactions. The average
number of dichlormapharsen injections in the improved cases was 16.2 (average dosage
41.4 mgm.). The average number of injections of dichlormapharsen in the unimproved
cases was 17.4 (average dosage of dichlormapharsen 37 mgm.).
Only 8 per cent of the improved cases were treated with dichlormapharsen alone without
the support of heavy metal, while 21 per cent of the unimproved cases were treated with
dichlormapharsen alone. The majority (66 per cent) of the cases treated with dichlor-
mapharsen and bismuth showed an improvement. The aforementioned factors suggest
that the serologic response to dichlormapharsen therapy is more favorable when the drug
is given accompanied or followed by heavy metal therapy (see table 2).
All cases (100 per cent) of early latent syphilis responded favorably to dichlormapharsen
therapy after 14.8 (average) injections of dichlormapharsen (average dosage 40.2 mgm.)
and 16 (average) injections of bismuth were given.
EFFECT OF DICHLORMAPHARSEN ON THE SEROLOGIC REACTION OF TERTIARY
SYPHILIS
(See Table 1)
Ten cases were observed. The serologic reaction improved in 7 cases (70 per cent) after
an average of 20 injections of dichiormapharsen (average dosage 49 mgm.) and 17.5 injec-
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tions of bismuth were given. There was no change in the serologic reaction in 3 cases after
an average of 24 injections of dichiormapharsen (average dosage 44 mgm.) and 26 injections
of bismuth were given.
EFFECT OF DICHLORMAPHARSEN ON THE SEROLOGIC REACTION OF CONGENITAL
SYPHILIS
Four cases were observed. In 2 cases the serologic reaction improved following 15 and
10 injections, respectively, of dichiormapharsen, and 6 and 12 injections, respectively, of
bismuth. In the other 2 cases the serologic reaction did not change following 9 and 15
injections, respective, of dichlormapharsen and 3 and 11 injections, respectively, of bis-
muth.
TABLE 1
Effect of dichiormapharsen on the serologic reactions of latent and tertiary syphilis
NBER OF CASES
BLOOD SEROLOGIC REAC-
TIONS REVERSED PARTIALLY
OR COMPLETELY
Late latent syphilis
Early latent syphilis
Tertiary syphilis
54
6
10
35 (64.8 per cent)
6 (100 per cent)
7 (70 per cent)
TABLE 2
The influence of the methods of administration of dichlormapharsen and bismuth on the
effectiveness of therapy of latent syphilis
PATIENTS TREATED WITE
DICELORMAPEARSEN
ALONE
PATIENTS TREATED BY TEE
CONCURRENT ADMINSSTRA-
TION OF DICHLORMAPHARSEN
AND BISMUTH
PATIENTS TREATED BY TEE
ALTERNATE METHOD OF
ADMINISTRATION OF DI-
CELORMAPHARSEN AND
BISMUTH
Total number of cases, 54..
Improved, 35
Unimproved, 19
7
3 (42 per cent)
4 (58 per cent)
11
8 (72 per cent)
3 (27 per cent)
36
24 (66.6 per cent)
12 (33.3 per cent)
WASSERMANN-FAST CASES
Five cases were studied. No change in the serologic reaction was noticed after an aver-
age of 27 injections of dichiormapharsen (average dosage 49 mgm.) and 21 injections of bis..
muth were given.
SPINAL FLUID EXAMINATIONS
The spinal fluid was examined in 76 cases; it was found to be positive in Sand negative in
71 cases. In one case following 35 injections of dichlormapharsen (total amount 1640 mgm.),
plus 30 injections of bismuth, the cell count 21, colloidal gold curve 1 1 1 2 1 1 0 0 0 0 0 and
trace of globulin changed to normal. The Wassermann reaction remained unchanged.
In another case a positive spinal fluid (Kahn 3+, cell count 7) became negative following 4
injections of neoarsphenamine, 12 injections of dichlormapharsen (total amount 500 mgm.)
and 24 of iodobismitol.
On the other hand, the spinal fluid of an early syphilitic patient who received 26 injec-
tions of dichlormapharsen (total amount 1740 mgm.), 26 of mapharsen (total amount 1070
mgm.), and 32 of bismuth, was found to be positive. Among the cases of early syphilis in
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which spinal tests were performed on or about the time when the treatment was completed,
or a few months later, the spinal fluid was found to be normal in 18 out of 19 patients.
UNTOWARD REACTIONS
Most of the patients tolerated dichiormapharsen well andshowed no untoward
reactions. Among the 194 patients who received altogether 3200 injections of
dichiormapharsen (injections given once or twice weekly), there were 58 who
developed 83 reactions. Fifty of these reactions were of a mild character such as
gastrointestinal, nausea, vomiting or headache, diarrhea or slight elevation of
the temperature, or mild dizziness, lasting for a few hours. All these mild
reactions occurred usually only once, sometimes more often, and did not recur
after the dosage of dichlormapharsen was decreased. One patient complained
once of frequent urination 24 hours following the injection. The urine was found
to be normal. One patient developed drowsiness and redness of the face for 24
hours. Nine patients showed a trace of albumen (few hayaline casts in 1 case)
during the treatment.
In most of the cases (6 out of 9) the urine became normal while the patient
was under treatment with dichiormapharsen and after 5—7 injections were given.
On several occasions immediately following the injection, four patients com-
plained of pain in the arm and shoulder which lasted for a few minutes to 1—2
hours. In one case the pains in the shoulder lasted 3 days. Twenty patients
developed 23 delayed reactions. Four patients developed pruritus without vis-
ible skin manifestations, 2 urticaria, 5 chills and fever up to 103—104, 6 developed
an erythematous scaly or papular eruption which lasted up to 3 weeks. One
patient developed a pustular eruption on the forehead and behind the ears, one
erythema, scaling and hyperkeratosis on the palms while receiving dichlorma-
pharsen. The eruption disappeared while the patient was under bismuth
therapy.
One patient developed purpura on the arms and thighs, one complained of
slight numbness in the leg, lasting for a few days. Of these 20 cases with de—
layed reactions, dichiormapharsen had to be abandoned entirely in 9; in 4 other
cases the drug was discontinued temporarily.
The ratio of immediate reactions to the general number of injections was 60
to 3200 (1:53). The ratio of delayed reactions to the general number of in-
jections was 23:3200 (1:39).
Icterus indices were done in 88 cases. In the patients confined to the hos-
pital, the tests were done once a week. The patients treated ambulatorily had
the icterus indices done only if some reaction appeared. Seven out of 88 cases
or 8 per cent presented an increase in the icterus index (10—18.7). However
there was not a single case of jaundice among our cases even in the one with the
icterus index 18.7. It is noteworthy that among the cases treated with ma-
pharsen (10) an increased icterus index (10—15) was seen in 14 out of 93 cases
or in 15 per cent.
Blood counts were done in cases in which important untoward reactions
occurred. In 9 out of 25 cases there were some changes in the blood counts
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following dichiormapharsen. In 5 cases those changes were some slight or
moderate anemia or some decrease in the number of polynuclear leucocytes
(down to 48 per cent), 3 cases however, developed leucopenia (white blood count
3900,4000,4750). In the first two cases the white blood count became normal
1f-2 weeks after dichiormapharsen was discontinued. In the third case the
patient was able to tolerate dichlormapharsen one year later. In one case the
number of the red blood cells was 3,240,000 following 3 injections of dichiorma-
pharsen. It increased to 4,200,000 after 7 more injections were given.
As for the untoward reactions in cases treated by the Eagle-Hogan method, a
detailed report will be given elsewhere (11). We may say however, that among
the 59 cases treated, in one case oniy was the reaction serious enough to warrant
the discontinuation of dichiormapharsen, while in the group treated with ma-
pharsen, the arsenical had to be discontinued in 7 out of 61 cases.
The lower toxicity of dichiormapharsen in comparison with mapharsen is also
shown by the following:
Twelve of our patients were treated previously with mapharsen and at that
time developed the following reactions: 10 gastrointestinal disturbances, head-
ache, nausea, fainting, 1 pain the arm following the injections, 1 pruritus. Nine
of these patients received on the average 20.7 injections of dichiormapharsen
without any after effects; the other 2 patients who reacted to the mapharsen
each time developed only once either a headache or nausea after dichiorma-
pharsen was given. In one case the patient developed headaches following
mapharsen. He tolerated dichlormapharsen well but finally developed some
erythema and scaling and hyperkeratosis on the palms while receiving dichlor-
mapharsen. The eruption disappeared while the patient received bismuth
injections. It is difficult to say whether or not this eruption was caused by
dichiormapharsen. In another case a patient who tolerated mapharsen well,
developed a mild diarrhea twice following injections of dichiormapharsen.
COMMENT
Dichiormapharsen appears to be an efficacious antisyphilitic drug. Primary,
secondary and tertiary lesions healed promptly following dichlormapharsen
therapy.
The serologic reaction of the blood improved in 64.8 per cent of cases of late
latent syphilis, in 100 per cent of early latent syphilis and 70 per cent of tertiary
syphilis. The serologic reaction of early syphilitic cases changed to negative
following 20.6 injections of dichiormapharsen given once or twice a week, and
24.6 injections when the Eagle-Hogan method was used.
Where the question of toxicity is concerned, it is important to note the small
number of reactions in general, the absence of cases of exfoliative dermatitis,
encephalitis and jaundice among the reactions mentioned.
I compared the data in this communication with those mentioned in two
papers on mapharsen (10, 12), and the following facts are noteworthy: (See
Tables 3 and 4).
The serologic reaction in late latent syphilis reversed partially or completely
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in 64.8 per cent of cases treated with dichlormapharsen and 64.6 per cent of
cases treated with mapharsen (10).
TABLE 3
Comparative effect of dichiormapharsen and mapharsen in early 8yphzlzs
Average treatment necessary for reversal of blood serologic reactions
a. Injections given once or twice weekly
NUMBER OF
CASES
JE0 AVERAGE TOTAl.
IUM AMOUNT GIVEN
20.6 1092 mgm.
19.4 1008 mgm.
Dichiormapharsen (injections given mostly twice
weekly)
Mapharsen (injections given mostly once weekly)...
12
8
b. Injections given three times weekly (method of Eagle-Hogan)
NUMBER OP
CASES
15
17
NUMBER OP
IN CTIONSVEN
24.6
21.3
AVERAGE TOTAL
AMOUNT OF THE
ARSENICAL
GIVEN
1406 mgm.
1190 mgm.
AVERAGE TOTAL
AMOUNT GIVEN
PER EILO OF
WEIGHT
21.7 mgm.
18.9 mgrn.
Dichlormapharsen
Mapharsen
TABLE 4
Corn pari8on of toxicity of dichiormapharsen and mapharsen
DIcHLORI&APHARSEN MAPHARSEN
a. Injections given once or twice weekly
Ratio of immediate reactions to the general
number of injections 1:53 1:60.4
Ratio of delayed reactions to the general
number of injections 1:139 1:121
Percentage of cases in which the arsenical had
to be discontinued because of important
reactions 7 12
Percentage of cases in which the icterus index
was elevated above 10 8 15
b. Injections given three times weekly
Number of cases treated by the Eagle-Hogan
method in which the arsenical was discon-
tinued because of important reactions 1 out of 59 cases 7 out of 61 cases
The serologic reaction in early cases became completely negative following
20.6 (average) injections of dichiormapharsen and 19.4 (average) injections of
mapharsen (10).
When the Eag'e-Hogan method was used in early cases (dosages of dichlor-
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mapharsen and mapharsen were the same: 1 mgm. per kilo of weight), the per-
centage of satisfactory results was 73.4 in cases treated with dichlormapharsen
and 76.4 per cent in cases treated with mapharsen (12).
The average number of injections given before the serologic reaction reversed
to negative was 24.6 of dichlormapharsen and 21.3 of mapharsen (12). The
average total amount of the drug given before the serologic reaction reversed
to negative was 1406 mgm. of dichlormapharsen and 1190 mgm. of mapharsen
(12).
As far as untoward reactions are concerned, the following facts are important.
In the group treated by the routine methods, the ratio of immediate reactions to
the general number of injections was 1:53 with dichlormapharsen and 1:60.4
with mapharsen (10). The ratio of delayed reactions to the general number of
injections was 1:139 with dichlormapharsen and 1:121 with mapharsen (10).
The number of cases in which the drug had to be discontinued because of im-
portant reactions was 13 out of 194 or 7 per cent of cases treated with dichlor-
mapharsen; and 19 out of 158 or 12 per cent of cases treated with mapharsen
(10).
The icterus index was found to be elevated above 10 in 8 per cent in cases
treated with dichlormapharsen and 15 per cent in cases treated with maphar-
sen (10).
As for the untoward reactions in 59 cases treated by the Eagle-Hogan method,
in one case only was the reaction serious enough to warrant the discontinuation
of dichiormapharsen; while when mapharsen was used (12), the drug had to be
discontinued in 7 out of 61 cases. The percentage of patients exhibiting treat
rnent reactions was much lower in the group treated with dichiormapharsen
(11) than in the group treated with mapharsen.
IMPRESSIONS
1. Dichiormapharsen is a good antisyphilitic drug.
2. It is somewhat less potent than mapharsen.
3. It is less toxic than mapharsen.
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